LD2D.3

ICD-11 MMS 2026-01

Gardner syndrome

Description

Gardner syndrome develops adenomatous polyps throughout the gastrointestinal tract, accompanied by extracolonic manifestations, including periampullary adenomas, papillary carcinoma of the thyroid, hepatoblastoma, osteomas of the mandible and skull, epidermal cysts, and desmoid tumours. Gardner syndrome is a term used to refer to patients in whom these extraintestinal features are unusually prominent.

Index terms

  • Gardner syndrome

Exclusions from above levels

  • 2E83.Z – Enchondromatosis
  • 4A01.31 – Ataxia-telangiectasia
  • 8C21.1 – familial dysautonomia [Riley-Day]
Show allHide
  • LA90.00 – Rendu-Osler-Weber disease
  • LD23 – Sturge-Weber syndrome
  • LD26.60 – Angio-osteohypertrophic syndrome
  • LD2C – Proteus syndrome
  • LD2F.1Y – Maffucci syndrome
  • http://id.who.int/icd/entity/733825440 – Inborn errors of metabolism

Sibling codes

  • LD2D.0 – Peutz-Jeghers syndrome
  • LD2D.1 – Neurofibromatoses
  • LD2D.2 – Tuberous sclerosis
  • LD2D.4 – Gorlin syndrome
  • LD2D.Y – Other specified phakomatoses or hamartoneoplastic syndromes
  • LD2D.Z – Phakomatoses or hamartoneoplastic syndromes, unspecified

Foundation entity

Gardner syndrome – http://id.who.int/icd/entity/1428130769

Part of: LD2D: Phakomatoses or hamartoneoplastic syndromes › 20: Developmental anomalies